Results 11 to 20 of about 1,367,795 (274)

Anemia in Lymphoproliferative Disorders [PDF]

Cancer Control, 1998
The onset of anemia in patients with lymphoproliferative disorders can be attributed to various causes, including autoimmune hemolytic anemia, pure red cell aplasia, and anemia of chronic disease. A variety of interventions can provide benefit.
Thomas P. Loughran
openaire   +3 more sources

Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract [PDF]

Haematologica, 2020
Indolent T-cell lymphoproliferative disorders of the gastrointestinal tract are rare clonal T-cell diseases that more commonly occur in the intestines and have a protracted clinical course.
Craig R. Soderquist, Nupam Patel, Vundavalli V. Murty, Shane Betman, Nidhi Aggarwal, Ken H. Young, Luc Xerri, Rebecca Leeman-Neill, Suzanne K. Lewis, Peter H. Green, Susan Hsiao, Mahesh M. Mansukhani, Eric D. Hsi, Laurence de Leval, Bachir Alobeid, Govind Bhagat   +15 more
doaj   +3 more sources

Hepatic and lung methotrexate-associated polymorphic lymphoproliferative disorders arising during postoperative follow-up of renal cell carcinoma: a case report

Journal of Medical Case Reports, 2023
Introduction Methotrexate induces lymphoproliferative disorders on rare occasions; however, its pathogenesis remains unknown. A clinical diagnosis based on imaging studies alone is often difficult.
Yoshi Miyamoto, Chihiro Kawasoe, Kaoru Ito, Nobuyuki Oguri, Takaya Murashima, Toyoharu Kamibeppu, Takahiro Nagai, Hiroki Takamori, Toshio Kamimura, Shoichiro Mukai, Yuichiro Sato, Toshiyuki Kamoto   +11 more
doaj   +2 more sources

Indolent T- and NK-Cell Lymphoproliferative Disorders of the Gastrointestinal Tract: Current Understanding and Outstanding Questions

Hemato, 2022
Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract are uncommon clonal neoplasms that have a protracted clinical course and limited response to therapy.
Craig R. Soderquist, Govind Bhagat
doaj   +2 more sources

Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders [PDF]

Journal for ImmunoTherapy of Cancer, 2016
The T-cell lymphoproliferative disorders are a heterogeneous group of non-Hodgkin’s lymphomas (NHL) for which current therapeutic strategies are inadequate, as most patients afflicted with these NHL will succumb to disease progression within 2 years of ...
Tycel Phillips, Sumana Devata, Ryan A. Wilcox   +2 more
doaj   +2 more sources

Endothelial dysfunction in patients with lymphoproliferative disorders and its changes in the course of polychemotherapy

Russian Open Medical Journal, 2020
The article is dedicated to contemporary views on the change of endothelial function in the patients with lymphoproliferative disorders prior to, and in the process of, chemotherapeutic treatment. Considering that possibilities of standard examination do
Igor L. Davydkin, Tatyana P. Kuzmina, Ksenia V. Naumova, Rais K. Khayretdinov, Olesya E. Danilova, Tatyana Yu. Stepanova, Aleksey M. Osadchuk, Elizaveta V. Mordvinova   +7 more
doaj   +2 more sources

Immunogenetic Background of Chronic Lymphoproliferative Disorders in Romanian Patients—Case Control Study

Medical Sciences
Background and Objectives: The implications of the genetic component in the initiation and development of chronic lymphoproliferative disorders have been the subject of intense research efforts. Some of the most important genes involved in the occurrence
Maria Tizu, Bogdan Calenic, Ion Maruntelu, Andreea Mirela Caragea, Adriana Talangescu, Larisa Ursu, Corina Rotarescu, Mariana Surugiu, Alexandra Elena Constantinescu, Ileana Constantinescu   +9 more
doaj   +2 more sources

Epstein–Barr virus mucocutaneous ulcer followed by Hodgkin lymphoma in multiple myeloma patient

Clinical Case Reports, 2022
Epstein–Barr virus mucocutaneous ulcers (EBV MCU) are B‐cell lymphoproliferative disorders associated with immunosuppression. We report EBV MCU in a multiple myeloma patient on lenalidomide maintenance after stem cell transplant that resolved with ...
Moriah Forster, Yuri Fedoriw, Sascha Tuchman, Natalie Grover   +3 more
doaj   +1 more source

Serum immunoglobulin levels in patients with lymphoproliferative diseases in Erbil, Kurdistan region, Iraq [PDF]

Zanco Journal of Medical Sciences, 2017
Background and objectives: Lymphoproliferative neoplasms are among the commonest human neoplasia. Immune dysregulation is frequently associated with many of these diseases, particularly those related to B-cell origin.
Karwan Bahram Maulood, Abdulkadir Aziz Alnaqshabandi   +1 more
doaj   +1 more source

HHVs AND LYMPHOPROLIFERATIVE DISORDERS

Mediterranean Journal of Hematology and Infectious Diseases, 2011
<p class="MsoNormal" style="text-align: justify; line-height: 200%; margin: 0cm 0cm 0pt; mso-layout-grid-align: none;"><span style="font-family: Times New Roman;"><span style="line-height: 200%; font-size: 10pt; mso-ansi-language: EN-US ...
G Riva, P Barozzi, C Quadrelli, Mario Luppi   +3 more
doaj   +3 more sources